Form D · Other
Akeso Biomedical, Inc.
Burlington, MA · CIK 0001604559
Offering snapshot reported Jun 6, 2023 · SEC filing
- Reported sold
- $25K Offering amount: $200K
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $5K Reported outside-investor minimum
- First sale
- May 29, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 6, 2023 | Initial | $25,000 | No comparison | 2 | SEC filing |
| Feb 12, 2021 | Initial | $573,905 | No comparison | 30 | SEC filing |
| Nov 8, 2019 | Initial | $597,325 | No comparison | 20 | SEC filing |
| Dec 5, 2018 | Amendment | $981,695 | $832,410vs May 18, 2018 | 51 | SEC filing |
| May 18, 2018 | Initial | $149,285 | No comparison | 17 | SEC filing |
| Mar 17, 2017 | Amendment | $2,515,000 | No comparison | 26 | SEC filing |
| Mar 23, 2016 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Jul 13, 2015 | Initial | $535,000 | No comparison | 10 | SEC filing |
| Dec 22, 2014 | Initial | $225,000 | No comparison | 9 | SEC filing |
| Apr 2, 2014 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity, Debt
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-483446
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| N/A | None |
Source: Form D, filed Jun 6, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Robert Calvin Goforth | Director |
| R. Calvin Goforth | Director |
| Mark Kidd | Executive |
| Greg W Lee | Director |
| Kevin Ohashi | Director |
| Bernard Prusaczyk | Director |
| Scott Roth | Director |
| Anthony J Sinskey | Director |
| Mark Wagstaff | Executive |
| Simon Williams | Director, Executive |
Issuer details
Industry: Other (See others in industry)
Address:
2400 District Avenue, Suite 110
Burlington, MA, 01803
Burlington, MA, 01803